Vodobatinib For Reducing Progression Of Parkinson's Disease

Abstract: The present disclosure relates to the c-Abl inhibitor vodobatinib, or a pharmaceutically acceptable salt thereof, for use in treating, delaying, inhibiting, or suppressing the progression of neurodegenerative diseases, preferably early stage Parkinson's disease, in a subject.

Patent Information

Application #

Filing Date

30 October 2024

Publication Number

49/2024

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED

17/B, Mahal Industrial Estate, Off Mahakali Caves Road, Andheri (East) Mumbai, Maharashtra 400093

Inventors

1. YAO, Siu-Long

Sun Pharma Advanced Research Company Ltd. 2 Independence Way Princeton, New Jersey 08540

2. RAMANATHAN, Vikram Krishna

B-601, Shangri La Apartments, Near Gorwa Lake, Subhanpura Vadodara, Gujarat 390023

3. DAMLE, Nitin Krishnaji

Beach House CHS, E8, 8th Floor Gandhigram Road, Juhu MUMBAI, MAHARASHTRA 400049

4. GOLDFINE, Andrew

521 Ramblewood Drive Bryn Mawr, Pennsylvania 19010

5. FAULKNER, Robert D.

102, Aledo Pointe Drive Aledo, Texas 76008

6. MANDHANE, Sanjay Nandlalji

79, Pratham Enclave, Sun Pharma Road Vadodara, Gujarat 390012

7. TALLURI, Ravi Sankar Prasad

802, Keystone Elita, Sector 15, Kharghar Navi Mumbai, Maharashtra 410210

Specification

Documents

Application Documents

#	Name	Date
1	202427083446-STATEMENT OF UNDERTAKING (FORM 3) [30-10-2024(online)].pdf	2024-10-30
2	202427083446-POWER OF AUTHORITY [30-10-2024(online)].pdf	2024-10-30
3	202427083446-FORM 18 [30-10-2024(online)].pdf	2024-10-30
4	202427083446-FORM 1 [30-10-2024(online)].pdf	2024-10-30
5	202427083446-DRAWINGS [30-10-2024(online)].pdf	2024-10-30
6	202427083446-DECLARATION OF INVENTORSHIP (FORM 5) [30-10-2024(online)].pdf	2024-10-30
7	202427083446-COMPLETE SPECIFICATION [30-10-2024(online)].pdf	2024-10-30